Passage BioPASG

13F holders, Q3 2025 (September 30)
2holders −37
0new positions
15sold out
$8.03avg. 13F price*

At the end of Q3 2025, 2 institutions reported holding Passage Bio Inc. (PASG) in their 13F filings, down 37 from Q2 2025. 0 opened new positions and 15 sold out. The largest holders were New Leaf Venture Partners, L.L.C. ($702K) and Cwm, LLC ($0).

Company
Passage Bio Inc.
Filed as
PASG (Q3 2025)
CUSIP
702712100
Latest filing quarter
Q3 2025

History

Number of 13F holders

0204060 Q1 2024: 51Q1 2024Q2 2024: 45Q2 2024Q3 2024: 45Q3 2024Q4 2024: 46Q4 2024Q1 2025: 42Q1 2025Q2 2025: 39Q2 2025Q3 2025: 2Q3 2025

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits15$297K

All 13F filers, Q2 2025 → Q3 2025: 3,152,008 shares sold, net −3,152,008 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

New Leaf Venture Partners, L.L.C. 1.63% Reduce -96.5% 87,426 $702K
Cwm, LLC 0.00% Reduce -80.0% 1 $0

"% of holder's portfolio" is PASG's weight in each manager's 13F, not the share of Passage Bio Inc. the manager owns.